Jane Street Group, LLC Uni Qure N.V. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Jane Street Group, LLC holds 326,516 shares of QURE stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

326,516

Previous 215,669 51.4%

Holding current value

$2.1 Million

Previous $1.12 Million 30.42%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $486,618 - $601,899	110,847 Added 51.4%	326,516 $1.46 Million
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $532,450 - $765,536	110,467 Added 105.0%	215,669 $1.12 Million
Q4 2023 Feb 14, 2024	SELL	$5.63 - $8.27 $1.05 Million - $1.55 Million	-187,173 Reduced 64.02%	105,202 $712,000
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $1.9 Million - $3.36 Million	-283,776 Reduced 49.25%	292,375 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $6.06 Million - $12.1 Million	545,192 Added 1761.01%	576,151 $6.6 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $343,444 - $423,703	-18,366 Reduced 37.23%	30,959 $623,000
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $679,880 - $1.03 Million	37,521 Added 317.87%	49,325 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $222,828 - $335,161	-13,123 Reduced 52.65%	11,804 $221,000
Q2 2022 Aug 16, 2022	SELL	$13.15 - $20.45 $441,853 - $687,140	-33,601 Reduced 57.41%	24,927 $464,000
Q1 2022 May 17, 2022	BUY	$14.54 - $21.5 $268,204 - $396,589	18,446 Added 46.02%	58,528 $1.06 Million
Q4 2021 Feb 15, 2022	BUY	$20.24 - $36.01 $277,247 - $493,264	13,698 Added 51.92%	40,082 $831,000
Q3 2021 Nov 16, 2021	SELL	$26.01 - $38.22 $1.06 Million - $1.56 Million	-40,848 Reduced 60.76%	26,384 $844,000
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $310,609 - $385,229	10,364 Added 18.22%	67,232 $2.07 Million
Q1 2021 May 18, 2021	BUY	$29.24 - $42.03 $909,568 - $1.31 Million	31,107 Added 120.75%	56,868 $1.92 Million
Q4 2020 Feb 17, 2021	SELL	$35.35 - $50.67 $383,158 - $549,212	-10,839 Reduced 29.61%	25,761 $930,000
Q3 2020 Nov 17, 2020	SELL	$35.98 - $47.66 $858,015 - $1.14 Million	-23,847 Reduced 39.45%	36,600 $1.35 Million
Q2 2020 Aug 17, 2020	BUY	$45.06 - $67.74 $2.33 Million - $3.5 Million	51,721 Added 592.72%	60,447 $2.72 Million
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $7,321 - $13,536	-183 Reduced 2.05%	8,726 $414,000
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $56,066 - $112,676	1,510 Added 20.41%	8,909 $639,000
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $228,602 - $446,054	-5,808 Reduced 43.98%	7,399 $291,000
Q2 2019 Aug 15, 2019	BUY	$52.76 - $82.19 $403,402 - $628,424	7,646 Added 137.49%	13,207 $1.03 Million
Q1 2019 May 16, 2019	BUY	$27.39 - $68.41 $152,315 - $380,428	5,561 New	5,561 $332,000
Q2 2018 Aug 15, 2018	SELL	$21.96 - $39.94 $209,169 - $380,428	-9,525 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.1 - $26.61 $162,877 - $253,460	9,525 New	9,525 $224,000

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Uni Qure N.V. Transaction History